Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision label changed from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T01:40:44.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated the study locations: new sites across multiple regions have been added and some sites removed, resulting in revised location availability and contact details on the Study Details page.
    Difference
    1%
    Check dated 2025-12-23T09:19:15.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision label updated from v3.3.1 to v3.3.2; no visible changes to study content.
    Difference
    0.0%
    Check dated 2025-12-01T16:48:23.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate PubMed publications are automatically filled from PubMed and may not be about the study; the revision tag was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:27:49.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new publication reference about Satralizumab in Thyroid Eye Disease was added to Publications, and a government funding lapse notice along with an older PubMed citation were removed.
    Difference
    0.3%
    Check dated 2025-11-17T06:25:09.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Added study site names Centro Oftalmologico Dr. Charles S.A., Medizinische Universitat Wien, and Universitatsklinikum Munster. Removed the previous diacritic-heavy spellings Centro Oftalmológico Dr. Charles S.A., Medizinische Universität Wien, Universitätsklinikum Münster from the Locations section.
    Difference
    0.3%
    Check dated 2025-11-10T03:35:40.000Z thumbnail image

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.